Juxtapid
NDC 10122-430, lomitapide mesylate, capsule, from Chiesi USA, Inc..
- Product NDC
- 10122-430
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA203858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOMITAPIDE MESYLATE30 mg/1
Pharmacologic classes
Cytochrome P450 3A4 Inhibitors [MoA]; Microsomal Triglyceride Transfer Protein Inhibitor [EPC]; Microsomal Triglyceride Transfer Protein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-430-28 | 10122043028 | 28 CAPSULE in 1 BOTTLE (10122-430-28) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/61a0be9d-ee58-43e0-b5cb-141011835081
Use it
Look up 10122-430 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-430 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-430. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.